… had a 9.2% higher risk of discontinuation compared with men, P = .002) and age (subjects
< 55 y of age were more likely to discontinue treatment than those > 70 y of age, P < .001). …

… Inhaled corticosteroids remain the cornerstone of anti-inflammatory treatment in asthma.
According to current asthma management guidelines, withdrawal … weeks after discontinuation of …

… and blinding, and reasons for withdrawal, on a score of 0 (… 50% reduction in the risk of relapse
(5% absolute risk reduction), … a 25% relative risk reduction (2.5% absolute risk reduction), …

… Recent studies of inhaled corticosteroid (ICS) therapy for managing stable chronic obstructive
pulmonary disease (COPD) have yielded conflicting results regarding survival and risk of …

To determine predictors for failed reduction of inhaled corticosteroids (ICS), in 50 subjects
with well-controlled asthma (age 43.7 [18–69]; 22 males) taking a median dose of 1,000 μ g …

… The role of long-acting β-agonists (LABA) added to inhaled corticosteroids (ICS) in the
management of asthma is extensively debated. We thought to assess the risk of asthma-related …

… When ICS are discontinued there is usually a gradual increase in symptoms and airway …
dose of inhaled corticosteroid and to reduce the requirement for oral corticosteroids [72], but this …

… inhaled corticosteroids also [58, 59], our findings suggest that these patients do not need
the additional medical therapy to reduce … no risk reduction in terms of mortality if an inhaled …

… a reduction in the risk of hospital admission for asthma. This result suggests that inhaled
corticosteroids … treatment with inhaled corticosteroids can reduce, by up to 80%, the risk of being …

… , inhaled corticosteroid treatment was associated with reductions in both the impairment and
risk … (2) Improvements in impairment and risk observed with inhaled corticosteroids were …